China.com: Happy new year !


Seite 1 von 1
Neuester Beitrag: 20.08.05 15:50
Eröffnet am:07.12.04 16:44von: Luck4YouAnzahl Beiträge:16
Neuester Beitrag:20.08.05 15:50von: KickyLeser gesamt:5.233
Forum:Börse Leser heute:1
Bewertet mit:


 

55 Postings, 8484 Tage Luck4YouChina.com: Happy new year !

 
  
    #1
07.12.04 16:44
924123 ist noch am schlafen; aber bald gehts los. Der "Aktionär" sieht Kursziel 12,-- €, Sponsorenschaften und Aktivität während der Spiele 2008 versprechen weiteres Potential. Also, ich bin drin und es geht bestimmt bald (jedenfalls  Richtung 7,--)los.
Viel Erfolg!

Luck4You  

770 Postings, 7460 Tage baerchen12 € ? nix dagegen...

 
  
    #2
07.12.04 17:09
ich beobachte die auch schon ne zeit lang...
wenn das wirklich richtung 12 € gehen soll is aber glaub ich noch zeit. einfachmal abwarten bis umsatz oder kurs anziehen.


mfg
baerchen  

770 Postings, 7460 Tage baerchennu aber loooos !!!!

 
  
    #3
17.12.04 15:08
so langsam könnte es gern mal losgehen;
vielleicht is heut ja ein guter tag zum einsteigen...


mfg
baerchen  

770 Postings, 7460 Tage baerchenna es wird ja....

 
  
    #4
22.12.04 21:56
kurs und volumen an der nasdaq ziehen heute abend nett an...ma sehn was morgen in f so kommt....

mfg
baerchen
   
Angehängte Grafik:
charts.gif
charts.gif

110 Postings, 7521 Tage HomeTradesie erwacht

 
  
    #5
27.12.04 18:37
heute um knapp 4 % aufwärts

bin auch schon ewig drin in dem teil
könnte wirklich losgehen

mfg ht  

549 Postings, 7859 Tage TaodonFuck noch eins

 
  
    #6
12.01.05 17:55
Was soll den das bitte ...tssss ..... das die DInger nie machen was man will !;)  

110 Postings, 7521 Tage HomeTradehey heut 11% knapp über 3 €

 
  
    #7
09.02.05 16:39
die müssen wir heut halten

mfg ht
 

2590 Postings, 7058 Tage brokeboyeine der wenigen

 
  
    #8
09.02.05 18:34
internetaktien, die ich nach 2003 nachgekauft habe.
mit diesen fundamentaldaten unbedingtes kz  > 7 Euro.

erwäge zukauf.  

4817 Postings, 7011 Tage martin30smCDC.Corp: Jemand Infos, warum die Aktie in den

 
  
    #9
07.08.05 13:12
USA am Freitag plötzlich 10% in die Höhe gesprungen ist?????  

4817 Postings, 7011 Tage martin30smKeiner Aktien von CDC.Corp bzw. Infos??? o. T.

 
  
    #10
07.08.05 15:57

4817 Postings, 7011 Tage martin30smWann kommen die Zahlen von CDC.Corp???? o. T.

 
  
    #11
12.08.05 21:20

79561 Postings, 8977 Tage KickyChinadotcom?

 
  
    #12
12.08.05 23:14

79561 Postings, 8977 Tage KickyVolumen steigt

 
  
    #13
12.08.05 23:16
HONG KONG, Aug 10, 2005 (BUSINESS WIRE) --CDC Corporation (NASDAQ:CHINA) will hold its quarterly conference call to discuss second quarter 2005 results on Friday, August 19th, 2005, at 9:00 am EDT. (Asian participants should note this is 9:00 pm Hong Kong time). An earnings release will precede the call, posting to the wires after 7:30 am EDT.

To listen, call the access number a few minutes before the scheduled start time of the call.

Date: Friday, August 19th, 2005 at 9:00 am EDT

USA-based Toll Free Number: +1 877 692 2592
US Toll Number: +1 973 582 2700

Passcode: Q2 CDC
Call Leader: Raymond Ch'ien

This call is being webcast by CCBN and can be accessed at CDC Corporation's corporate web site at www.cdccorporation.net or directly at: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c= 78433&eventID=987204 (Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.)

 

4817 Postings, 7011 Tage martin30smGute Zahlen: Aktie 9% plus!

 
  
    #14
19.08.05 18:31
19.08.2005 13:32
CDC Corporation reports revenues of US$64.6 million for Q2 2005, Up 44% year-on-year



Year-on-Year US GAAP -- Total revenue rose 44% to US$64.6 million from US$44.9 million in Q2 2004 -- Gross profit increased 39% to US$36.0 million from US$25.9 million in Q2 2004 -- Gross margin was 56%, and was 58% in Q2 2004 -- Income before taxes was US$2.9 million compared to a loss before taxes of US$0.5 million in Q2 2004 -- Net income was US$36,000 compared to a net loss of US$2.0 million in Q2 2004 Year-on-Year Non-GAAP* -- Non-GAAP net income was US$5.4 million compared to Non-GAAP net income of US$2.7 million in Q2 2004 -- Non-GAAP net cash and cash equivalents, net of total debt, were US$220.6 million at June 30th, 2005

HONG KONG, Aug. 19 /Xinhua-PRNewswire-FirstCall/ -- CDC Corporation (Nachrichten) (Nasdaq: CHINA; http://www.cdccorporation.net/ ) today announced its unaudited financial results for the second quarter of 2005 under US GAAP.

Second Quarter 2005

The company reported revenues of US$64.6 million, an increase of 44% from US$44.9 million in Q2 2004. Second quarter 2005 gross profit was US$36.0 million, up 39% from US$25.9 million in Q2 2004. Gross margin was 56% compared to 58% in Q2 2004. Operating income was US$1.2 million compared to an operating loss of US$2.0 million in Q2 2004. Income before taxes was US$2.9 million compared to a loss before taxes of US$0.5 million in Q2 2004. Net income was US$36,000 compared to a net loss of US$2.0 million in Q2 2004. Basic earnings per share was less than 1 US cent compared to loss per share of 2 US cents in Q2 2004.

Total software revenue in Q2 2005 was US$42.5 million, up 76% from US$24.1 million in Q2 2004 due significantly to the company's acquisition of Ross Systems in August 2004. Software license revenues for Q2 2005 were US$10.7 million, or 25% of total software revenues for the quarter. Software services and maintenance revenues were US$31.8 million, or 75% of total software revenues for the quarter. The geographic breakdown for software revenues were 49% in North America, 40% in Europe, and 10% in Asia Pacific.

Total mobile services and applications ("MVAS") revenue for Q2 2005 was US$8.6 million, up 18% from US$7.3 million in Q1 2005 and up 13% from US$7.6 million in Q2 2004. In Q1 2005, the company changed the presentation for its MVAS revenue from a net basis (excluding the portion of the MVAS revenue paid to the mobile operators) to a gross basis (including the portion of the MVAS revenue paid to the mobile operators) in response to significant changes in operations of the MVAS business in China. As a result, the 2004 historical MVAS revenue amounts are presented on a net basis while 2005 amounts are presented on a gross basis. Total Q2 2004 MVAS revenue on a gross basis would have been $10.3 million. SMS-based MVAS revenue for Q2 2005 was US$5.0 million, down 43% from Q2 2004 on a gross basis. Revenue from advanced mobile products for Q2 2005 was US$4.0 million, up 85% from US$2.2 million in Q2 2004 on a gross basis.

Operating expenses totaled US$34.8 million, an increase of 24% from US$28.0 million reported in Q2 2004. The year-on-year increase in operating expenses is partially due to the company's acquisition of Ross Systems and the consolidation of its results, including its operating expenses, since such time.

As of June 30th, 2005, the company had approximately 111 million common shares outstanding.

In order to improve its long term financial results, the company has recently embarked upon a strategic evaluation of its businesses and will take steps that may include the standardization of certain policy and procedures, reduction of operating expenses, incurrence of charges such as restructuring charges, additional investment, impairment of assets and discontinuation of operations together with the attendant gains or losses from such impairments or disposals. These initiatives may result in a near term adverse effect on the financial results of the company.


Company Highlights -- Ross Systems, the company's enterprise software solutions subsidiary, reported its highest quarterly total revenue in five years. Ross added 14 new customers during the quarter, including nine new international customers and several key Life Science industry wins. The subsidiary achieved "Microsoft Gold Partner" status for the iRenaissance suite. Five customers purchased the subsidiary's Enterprise Performance Management ("EPM") suite within the first 90 days of launch at the end of the first quarter. -- Pivotal, the company's customer relationship management ("CRM") software subsidiary, added 24 new customers during the quarter, and more than 50 existing customers made additional purchases in the quarter. Pivotal's financial services vertical had a particularly strong quarter. In May, the company released Pivotal Medical Devices, a new CRM system specifically for the medical device community and TecHome Builder Magazine named the company's front office home builder product line as the "High Impact Product of the Year." -- IMI, the company's supply chain, warehouse and order management software subsidiary, released two products during the second quarter. IMI Order 9.1, built upon service oriented architecture, employs web services to offer a new set of graphical customer service workbenches that provide key business parameters and customer, product and order statistical information. The new release of IMI Warehouse Management System 5.0 contained enhancements such as production monitoring and dynamic slotting. The subsidiary also launched a new prospect, customer and partner website at http://www.imiamericas.com/ . -- CDC Software Asia Pacific, the company's enterprise software sales and marketing subsidiary for the region, achieved "Microsoft Gold Partner" status in China and Japan. The subsidiary continued to gain traction in the Japan market and opened a Technical Support Center in Tokyo. -- Praxa, the company's Australian business services subsidiary, added several new customer engagements in Q2 2005 and signed a significant 18-month support contract with its existing customer, Australia Post. -- The company's mobile applications business posted its second-straight quarter of revenue improvements as its more balanced portfolio of SMS and advanced mobile products, including Interactive Voice Response ("IVR"), Wireless Application Protocol ("WAP") and Multimedia Messaging Services ("MMS"), continues to gain traction in China. Advanced mobile product revenues on a gross basis for all periods, which include WAP, IVR and MMS products, in Q2 2005 were 45% of total MVAS revenues as compared to 20% in Q2 2004 and 42% in Q1 2005. -- The company's portal, http://www.china.com/, continued to boost page views and advertising revenue in Q2 2005 chiefly from enhanced content. Since the end of the quarter, China.com Inc. announced three high-profile exclusive partnerships with English Premiere League football clubs Arsenal, Liverpool and Manchester United. All three global sports brands have appointed the subsidiary as the exclusive partner and provider of Internet and mobile applications and services for China and Taiwan, and the exclusive partner and provider of Internet applications and services for Hong Kong and Macau. The official Chinese online destination for all three clubs will be operated, hosted and promoted by the portal, http://www.china.com/ . -- In mid-July and following the successful open beta test period in Q2 2005, 17game, the online game business in China which is 48%-owned by China.com Inc., commercially launched "Yulgang." The peak concurrent users have hit 160,000 and there are now over 6.0 million registered users. Management expects continued peak concurrent user growth in the second half of 2005.

"The company is pleased with the revenue achievements from our software subsidiaries and the strong customer and industry acceptance of our products such as Ross Systems' EPM and Pivotal's Financial Services and Home Building offerings. We are encouraged by the progress of the company's initial sales infrastructure build out in Japan," said Executive Chairman and CEO, Dr. Raymond Ch'ien.

Ch'ien continued, "On the mobile services front, we are pleased with revenue gains and expect growth in the second half of 2005 as the company rolls out more 2.5G mobile products. We have made positive strides in improving our portal websites with deep specialized content and in establishing solid exclusive strategic partnership agreements with global sporting super brands like Manchester United, Arsenal and Liverpool. We expect traffic gains at the portals to attract more online advertising spend in the coming quarters."

*Non-GAAP Financial Measures

To supplement the financial measures prepared in accordance with United States generally accepted accounting principles ("GAAP"), the company uses non-GAAP financial measures for net income and other line items, which are adjusted from results based on GAAP. These non-GAAP measures are provided to enhance the user's overall understanding of the company's current financial performance and its prospects for the future. The company believes the non- GAAP results provide useful information to both management and investors. All references to non-GAAP in this press release should be read in conjunction with the more detailed financial statements included at the end of this press release.

In particular, the adjusted income presentation below may be useful for investors to assess the impact of recent acquisitions and non-recurring events. The adjusted cash presentation below may be useful to assess the company's liquidity. Although the company continues to report GAAP results to investors, it believes the inclusion of non-GAAP financial measures provides further clarity in its financial reporting. These non-GAAP financial measures may be different from non-GAAP financial measures used by other companies, and should be considered in addition to results prepared in accordance with GAAP, but should not be considered a substitute for or superior to GAAP measures. The non-GAAP financial measures included in this press release have been reconciled to the nearest GAAP measures.


Reconciliation From GAAP Results to Non-GAAP Results: Q2 2004 Q2 2005 (In US$ Thousands, except per share data) GAAP net income/ (loss) (2,041) 36 Add back revenue impact of deferred maintenance Revenue write down related to the acquisition of subsidiaries 946 204 Add back amortization of purchased intangibles related to the acquisition of subsidiaries 2,277 3,327 Add back stock compensation expenses related to the acquisition of subsidiaries 827 272 Add back deferred tax impact related to the acquisition of subsidiaries (954) 1,538 Add back litigation provision 1,613 -- Non-GAAP net income 2,668 5,377 Non-GAAP basic earnings per share 0.026 0.048 Weighted average no. of shares 104,252,061 110,988,609 Reconciliation of GAAP Cash and Cash Equivalents to Non-GAAP Cash and Cash Equivalents (In US$ Thousands) Q1 2005 Q2 2005 Cash and cash equivalents 77,829 73,859 Add restricted cash 3,845 3,738 Add debt securities 173,254 169,531 Less total debt (28,886) (26,506) Non-GAAP cash and cash equivalents, net of total debt 226,042 220,622 Unaudited and Preliminary Financial Information

The financial information included in this press release is unaudited and preliminary. The quarterly financial information included herein is subject to adjustment pending the completion of the 2005 full year audit by the company's independent registered public accounting firm, Ernst&Young. Adjustments to the Q2 financial statements and information may be identified when the 2005 full year audit work is completed, which could result in significant changes which may need to be made to the company's preliminary Q2 unaudited financial information set forth in this press release. The 2005 audited consolidated financial statements and related notes will be included in the company's Annual Report on Form 20-F for the year ending December 31st, 2005.

Conference Call

CDC Corporation will hold a conference call to review its second quarter 2005 results at 9:00 am EDT on Friday, August 19th, 2005 (9:00 pm on August 19th, 2005 -- Hong Kong time). Investors can call:


USA and CANADA Toll Free Number: +1-877-692-2592 INTERNATIONAL Toll Number: +1-973-582-2700

The call leader is Dr. Raymond Ch'ien. Alternatively, the conference call can be heard via the Internet at: http://phx.corporate-ir.net/phoenix.zhtml?p=irol- eventDetails&c=78433&eventID=987204 .

Instant Replay

For those unable to call in or listen to the live broadcast via the web, a replay will be available after the call at http://www.cdccorporation.net/ under INVESTOR RELATIONS or via Instant Replay by calling INTERNATIONAL Toll Number: 973-341-3080, US and CANADA Toll Free Number: 877-519-4471, Passcode: 6320221. The instant replay will be available until September 5th, 2005.

About CDC Corporation

CDC Corporation is focused on enterprise software, business services, mobile applications and internet media. The company has approximately 2,000 employees with operations in 17 countries.

For more information about CDC Corporation, please visit the website http://www.cdccorporation.net/ .

Cautionary Note Regarding Forward-Looking Statements

This press release includes "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995, including statements relating to the effect on the financial results of the company resulting from the strategic evaluation of its businesses and the measures taken in connection therewith, market acceptance of Ross' EPM suite, Pivotal's Medical Devices system, and IMI's order management and warehouse management products, growth of CDC Software Asia Pacific in the Japan market, the continued ability of the portal to boost page views and advertising revenue, the ability of the partnerships with Arsenal, Liverpool and Manchester United to increase traffic content and online advertising spend for the portal, the mobile applications business's ability to transform from a SMS focused service provider to a provider of a more balanced portfolio of services on other platforms, expectations of revenue gains and growth in the mobile services business as the company rolls out more 2.5G mobile products, and expected growth in the number of concurrent players for the Yulgang online game. These statements are based on management's current expectations and are subject to risks and uncertainties and changes in circumstances. There are important factors that could cause actual results to differ materially from those anticipated in the forward looking statements, including the following: (a) the ability to realize strategic objectives by taking advantage of market opportunities in targeted geographic markets; (b) the ability to make changes in business strategy, development plans and product offerings to respond to the needs of current, new and potential customers, suppliers and strategic partners; (c) the ability to integrate operations or new acquisitions in accordance with the company's business strategy; (d) the effects of restructurings and rationalization of operations; (e) the ability to address technological changes and developments including the development and enhancement of products; (f) the ability to develop and market successful products and services on the WAP, IVR and MMS platforms; (g) the entry of new competitors and their technological advances; (h) the need to develop, integrate and deploy enterprise software applications to meet customer's requirements; (i) the possibility of development or deployment difficulties or delays; (j) the dependence on customer satisfaction with the company's software products and services; (k) continued commitment to the deployment of the enterprise software solutions; (l) risks involved in developing software solutions and integrating them with third-party software and services; (m) the continued ability of the company's enterprise software solutions to address client-specific requirements; (n) demand for and market acceptance of new and existing enterprise software and services and the positioning of the company's solutions; and (o) the ability of staff to operate the enterprise software and extract and utilize information from the company's enterprise software solutions. Further information on risks or other factors that could cause results to differ is detailed in filings or submissions with the United States Securities and Exchange Commission made by CDC Corporation in its Annual Report for the year ended December 31, 2004 on Form 20-F filed on June 30, 2005. All forward-looking statements included in this press release are based upon information available to management as of the date of the press release, and you are cautioned not to place undue reliance on any forward looking statements which speak only as of the date of this press release. The company assumes no obligation to update or alter the forward looking statements whether as a result of new information, future events or otherwise.


For further information, please contact: Media Relations Investor Relations Anne Yu, VP Corporate Planning Craig Celek, VP Investor Relations Tel: +852-2237-7020 Tel: +1-212-661-2160 Fax: +852-2571-0410 Fax: +1-646-827-2421 Email: media@cdccorporation.net Email: craig.celek@cdccorporation.net CDC Corporation Consolidated Statement of Operations (Amounts in thousands of U.S. dollars, except per share data) Three months Three months ended, ended, June 30, 2004 June 30, 2005 (unaudited) (*) (unaudited) Revenues Software 24,142 42,535 Business services 10,383 10,218 Mobile services and applications 7,580 8,585 Advertising and marketing activities 2,754 3,245 44,859 64,583 Cost of revenues Software (9,317) (16,081) Business services (6,858) (6,952) Mobile services and applications (1,651) (4,250) Advertising and marketing activities (1,120) (1,322) (18,946) (28,605) Gross profit 25,913 35,978 Gross margin % 58% 56% Selling, general and administrative expenses (20,503) (25,651) Research and development expenses (4,549) (5,037) Depreciation and amortization expenses (2,906) (4,110) (27,958) (34,798) Operating income/(loss) (2,045) 1,180 Interest income 2,403 2,103 Interest expense (492) (274) Gain on disposal of available-for-sale securities 47 -- Impairment of available-for-sale securities (373) -- Gain/(loss) on disposal of subsidiaries and investments (29) 338 Share of losses in equity investees -- (489) Income/(loss) before income taxes (489) 2,858 Income taxes expenses (883) (2,201) Income/(losses) before minority interests (1,372) 657 Minority interests in income of consolidated subsidiaries (583) (640) Income/(losses) from continuing operations (1,955) 17 Discontinued operations Income/ (loss) from operations (86) 22 Loss from disposals -- (3) Net income/(losses) (2,041) 36 Basic earnings/ (losses) per share (0.020) 0.000 Diluted earnings/ (losses) per share (0.020) 0.000 Weighted average number of shares 104,252,061 110,988,609 Diluted number of shares 104,252,061 111,322,902 Reconciliation from GAAP results to non-GAAP results: GAAP net income/ (loss) (2,041) 36 Add back revenue impact of deferred maintenance revenue write down related to the acquisition of subsidiaries 946 204 Add back amortization of purchased intangibles related to the acquisition of subsidiaries 2,277 3,327 Add back stock compensation expenses related to the acquisition of subsidiaries 827 272 Add back deferred tax impact related to acquisition of subsidiaries (954) 1,538 Add back litigation settlement 1,613 -- Net income - non-GAAP 2,668 5,377 Basic earnings per share - non-GAAP 0.026 0.048 (*) The unaudited statement of operations for the quarter ended June 30, 2004 has been adjusted to reflect year-end audit adjustments affecting the quarter. Such adjustments were primarily related to purchase accounting. CDC Corporation Consolidated Balance Sheets (Amounts in thousands of U.S. dollars) March 31, June 30, 2005 2005 (unaudited) (unaudited) ASSETS Current assets: Cash and cash equivalents 77,829 73,859 Restricted cash 3,845 3,738 Accounts receivable 42,163 44,464 Deposits, prepayments and other receivables 10,712 11,045 Available-for-sale debt securities 140,979 137,006 Restricted debt securities 32,275 32,525 Available-for-sale equity securities 552 537 Deferred tax assets 846 560 Property held for sale 3,151 -- ________ ________ Total current assets 312,352 303,734 Loan receivables 25,000 25,000 Interest receivables 1,063 1,250 Property and equipment, net 7,352 7,123 Goodwill 189,994 188,667 Intangible assets 78,926 78,549 Investment in equity investees 3,647 2,829 Investments under cost method 229 220 Deferred tax assets -- 29 Other assets 4,376 4,798 ________ ________ Total assets 622,939 612,199 ________ ________ ________ ________ LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable 12,116 13,240 Other payables 3,091 4,179 Purchase consideration payable 15,147 2,816 Accrued liabilities 33,024 32,926 Accrued pension liability 871 780 Short-term loans 27,368 26,506 Long-term bank loans, current portion 1,518 -- Deferred revenue 35,780 35,800 Income tax payable 2,732 3,044 Deferred tax liabilities -- 4 ________ ________ Total current liabilities 131,647 119,295 Deferred tax liabilities 4,838 4,487 Other liabilities 369 372 Accrued pension liability 1,283 1,088 Minority interests 47,804 48,601 Shareholders' equity: Share capital 28 28 Additional paid-in capital 674,258 674,926 Treasury stock (4,067) (4,032) Accumulated deficits (233,172) (233,136) Accumulated other comprehensive income (49) 570 ________ ________ Total shareholders' equity 436,998 438,356 ________ ________ Total liabilities and shareholders' equity 622,939 612,199 ________ ________ ________ ________ Number of outstanding shares 110,965,246 111,108,996



 

4817 Postings, 7011 Tage martin30smAusbruchsversuch läuft

 
  
    #15
19.08.05 18:33
19.08.2005 17:19
CDC CORPORATION - Ausbruchsversuch läuft
CDC Corporation (CHINA) : 3,49 $ (+9,06%)

Aktueller Tageschart (log) seit September 2004 (1 Kerze = 1 Tag).

Diagnose: Bei 2,37 $ wurde der Abverkauf der Aktie von CDC Corporation (Nachrichten) im April gestoppt, nach einem nochmaligen Test dieses Niveaus im Mai kann sich der Kurs bereits deutlich erholen. Heute erfolgt ein weiterer Ausbruchsversuch über die bei 3,45 Punkten liegende Widerstandslinie, an der exp. GDL 200 (EMA 200, rot) prallt der Kurs aber wieder nach unten ab.

Prognose: Ein klarer Ausbruch über 3,45 $ auf Schlussbasis würde hier ein neues Kaufsignal generieren, was abzuwarten bleibt. Fällt die Aktie nach dem Scheitern am EMA 200 jetzt deutlicher zurück, wird hingegen ein Test des bei 3,00 $ liegenden mittelfristigen Aufwärtstrends wahrscheinlich.


 

79561 Postings, 8977 Tage Kickyschöner 3Monatschart

 
  
    #16
20.08.05 15:50

   Antwort einfügen - nach oben